B
82.11
0.66 (0.81%)
| 前收盘价格 | 81.45 |
| 收盘价格 | 81.05 |
| 成交量 | 732,483 |
| 平均成交量 (3个月) | 1,081,683 |
| 市值 | 5,247,321,600 |
| 价格/销量 (P/S) | 10.06 |
| 股市价格/股市净资产 (P/B) | 17.43 |
| 52周波幅 | |
| 利润日期 | 30 Apr 2025 - 5 May 2025 |
| 营业毛利率 | -13.19% |
| 营业利益率 (TTM) | -28.15% |
| 稀释每股收益 (EPS TTM) | -1.07 |
| 季度收入增长率 (YOY) | 103.40% |
| 总债务/股东权益 (D/E MRQ) | 242.51% |
| 流动比率 (MRQ) | 2.85 |
| 营业现金流 (OCF TTM) | -192.59 M |
| 杠杆自由现金流 (LFCF TTM) | -76.03 M |
| 资产报酬率 (ROA TTM) | -11.89% |
| 股东权益报酬率 (ROE TTM) | -31.26% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看跌 |
| Biotechnology (全球的) | 混合的 | 看跌 | |
| 股票 | Blueprint Medicines Corporation | 看涨 | 看涨 |
AIStockmoo 评分
1.5
| 分析师共识 | 5.0 |
| 内部交易活动 | NA |
| 价格波动 | 3.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -2.5 |
| 平均 | 1.50 |
|
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 0.87% |
| 机构持股比例 | 106.72% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 150.00 (Scotiabank, 82.68%) | 购买 |
| 中 | 128.50 (56.50%) | |
| 低 | 100.00 (Morgan Stanley, 21.79%) | 保留 |
| 平均值 | 127.90 (55.77%) | |
| 总计 | 8 购买, 2 保留 | |
| 平均价格@调整类型 | 93.28 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Wedbush | 16 Apr 2025 | 128.00 (55.89%) | 购买 | 80.98 |
| Needham | 08 Apr 2025 | 133.00 (61.98%) | 购买 | 79.22 |
| 14 Feb 2025 | 133.00 (61.98%) | 购买 | 93.94 | |
| Morgan Stanley | 20 Mar 2025 | 100.00 (21.79%) | 保留 | 88.47 |
| Jefferies | 17 Mar 2025 | 135.00 (64.41%) | 购买 | 92.14 |
| Scotiabank | 07 Mar 2025 | 150.00 (82.68%) | 购买 | 87.12 |
| Citizens Capital Markets | 03 Mar 2025 | 125.00 (52.23%) | 购买 | 89.75 |
| HC Wainwright & Co. | 14 Feb 2025 | 135.00 (64.41%) | 购买 | 93.94 |
| JMP Securities | 14 Feb 2025 | 125.00 (52.23%) | 购买 | 93.94 |
| JP Morgan | 04 Feb 2025 | 129.00 (57.11%) | 购买 | 113.40 |
| Piper Sandler | 27 Jan 2025 | 119.00 (44.93%) | 保留 | 113.88 |
| 显示更多 | ||||
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合